The Nursing Home Paradox

The title of this post should have been given to a study that was published in 2022. I have missed that publication until recently, perhaps because of its uninformative title: “Nursing home quality, COVID-19 deaths, and excess mortality.” There is …

Pfizer Lied to Us Again

There used to be a time where claims from pharmaceutical companies may have been treated with some degree of skepticism from major institutions and media outlets.

Yet in late 2020 and into 2021, suddenly skepticism turned to complete blind faith. …

Is Paxlovid a Dud?

Of all the antiviral drugs for Covid-19, Pfizer’s Paxlovid has been the most successful. Not for its safety and efficacy, but for its ability to earn the company billions in profits despite being largely ineffective for most people.

In November …